AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2020
Feb 19, 2020
29821_dirs_2020-02-19_42c5c28d-7661-48f7-8094-0d6242094177.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2020-02-18
Reporting Person: Pierce David A (EVP Pres MedSurg)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-19 | Common Stock | S | 1511.0000 | $42.3100 | Disposed | 32540.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-18 | Deferred Stock Units | $ | A | 10673.0000 | Acquired | 2024-02-18 | Common Stock (10673.0000) | Direct |
| 2020-02-18 | Stock Option (Right to Buy) | $42.1600 | A | 39823.0000 | Acquired | 2030-02-18 | Common Stock (39823.0000) | Direct |
Footnotes
F1: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F3: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.
F4: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.